NIM
FLXN

NXG Investment Management’s Flexion Therapeutics, Inc. FLXN Stock Holding History

NXG Investment Management’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-20,835
Closed -$171K – 136
2021
Q2 		$171K Buy
20,835
+4,228
+25% +$36K 0.02% 112
2021
Q1 		$149K Sell
16,607
-2,293
-12% -$26.3K 0.02% 110
2020
Q4 		$218K Sell
18,900
-35,843
-65% -$417K 0.03% 124
2020
Q3 		$570K Buy
54,743
+1,051
+2% +$12.9K 0.08% 78
2020
Q2 		$706K Buy
53,692
+16,828
+46% +$175K 0.08% 77
2020
Q1 		$290K Buy
36,864
+17,082
+86% +$257K 0.04% 89
2019
Q4 		$409K Sell
19,782
-548
-3% -$9.24K 0.02% 107
2019
Q3 		$279K Buy
+20,330
New +$241K 0.01% 105

Other funds holding FLXN

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
CC
Clearline Capital New York $1.29B AUM 38.13% 1-Year Est. Return
NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return